Screener
Eli Lilly LLY Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $8.95B+165% | $5.28B+70.8% | $7.27B+122% | $9.79B+191% | $3.38B+4.7% | ||
| $20.08B+41.7% | $18.43B+53.1% | $17.76B+61.4% | $16.11B+56.5% | $14.17B+28.5% | ||
| $16.76B+52.1% | $14.49B+56.1% | $13.7B+82.0% | $12.22B+65.4% | $11.02B+72.3% | ||
| $64.67B+29.7% | $54.84B+32.9% | $55.63B+69.9% | $62.07B+97.6% | $49.85B+65.1% | ||
| $29.29B+42.7% | $26.54B+43.7% | $24.68B+44.3% | $22.32B+38.0% | $20.53B+38.4% | ||
| $8.85B+53.3% | $6.13B+6.2% | $5.9B+2.2% | $5.9B+2.2% | $5.77B0.0% | ||
| $18.11B+207% | $7.37B+22.7% | $6.52B+5.8% | $6.45B-1.4% | $5.91B-11.0% | ||
| $142.28B+41.0% | $116.58B+30.4% | $112.48B+42.9% | $114.94B+52.0% | $100.92B+40.4% | ||
| $6.11B+50.0% | $5.03B+46.1% | $5.38B+66.6% | $4.26B+47.7% | $4.08B+39.3% | ||
| $7.05B+23.2% | $4B-0.4% | $1.64B-68.0% | $1.63B-21.3% | $5.72B+10.9% | ||
| $47.74B+22.4% | $36.63B+21.8% | $35.23B+24.1% | $40.14B+62.7% | $39.02B+43.9% | ||
| $47.86B+40.0% | $39.37B+14.1% | $40.87B+43.3% | $40.87B+40.7% | $34.18B+44.0% | ||
| $60.66B+39.3% | $48.74B+12.1% | $50.71B+40.6% | $50.94B+39.1% | $43.55B+40.0% | ||
| $588M-0.7% | $590M-0.4% | $590M-0.3% | $591.4M-0.4% | $592M-0.4% | ||
| $31.89B+83.5% | $29.51B+95.5% | $24.47B+80.7% | $22.25B+63.3% | $17.38B+31.9% | ||
| $33.88B+85.4% | $31.2B+97.9% | $26.54B+85.9% | $23.79B+67.1% | $18.27B+34.7% | ||
| $142.28B+41.0% | $116.58B+30.4% | $112.48B+42.9% | $114.94B+52.0% | $100.92B+40.4% |
FAQ
- What are Eli Lilly's total assets?
- Eli Lilly (LLY) holds $142.28B in total assets, up 41.0% year over year.
- How much debt does Eli Lilly have?
- Eli Lilly carries $54.9B in total debt against $33.9B of shareholders' equity, a debt-to-equity ratio of 1.62.
- How much cash does Eli Lilly have?
- Eli Lilly holds $9.0B in cash and equivalents.
- Can Eli Lilly cover its short-term obligations?
- Its current ratio is 1.35 — current assets exceed current liabilities.
- Where does Eli Lilly's balance sheet data come from?
- Every line is extracted from Eli Lilly's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
